Thyrocare Technologies News Today

A Velumani, the founder and chairman of Thyrocare Technologies, has persevered through significant financial setbacks to build a successful chain of diagnostic and preventive care laboratories.

Flipkart enters crowded healthtech sector with SastaSundar acquisition Mumbai: The Flipkart Group has signed a deal to acquire a majority stake in online pharmacy Sastasundar Marketplace to launch its own healthcare business amid a pandemic-triggered consolidation in India’s healthtech industry. Flipkart Health+, as the new entity will be known, will leverage the Walmart Inc.-controlled company’s

Although born into humble beginnings, his journey from utter poverty to prosperity, is, in many ways, a story of an unyielding work ethic.

Born to a landless farmer father, Velumani's family faced hardships, often unable to afford basic necessities like clothing.

Biggest Nifty losers included Power Grid Corporation, Apollo Hospitals, Eicher Motors and Maruti Suzuki, while HUL, Infosys, TCS and Bharti Airtel were among the gainers

He earned a PhD in Thyroid Physiology while working with BARC, a nuclear research facility based in Mumbai.

Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The

Thyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 3362.49 Crore) operating in Hospitals & Allied Services sector.

Thyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 3228.73 Crore) operating in Hospitals & Allied Services sector.

ICICI Securities is bullish on Thyrocare Technologies recommended buy rating on the stock with a target price of Rs 740 in its research report dated December 13, 2023.